three
patient
fulfil
case
definit
probabl
develop
liver
derang
includ
studi
briefli
case
definit
fever
c
higher
cough
difficulti
breath
radiograph
evid
infiltr
consist
pneumonia
respiratori
distress
syndrom
either
histori
exposur
patient
sar
lack
respons
empir
antimicrobi
coverag
typic
atyp
pneumonia
inform
consent
obtain
patient
percutan
liver
biopsi
perform
look
caus
elev
liver
enzym
common
caus
hepat
exclud
serolog
test
includ
viru
igm
antibodi
b
core
igm
hepat
b
surfac
antigen
c
antibodi
cytomegaloviru
antigen
abdomin
ultrasonographi
perform
rule
lesion
biliari
tract
diseas
patient
receiv
antimicrobi
coverag
pneumonia
ceftriaxon
clarithromycin
levofloxacin
alon
combin
therapi
use
oral
ribavirin
mg
twice
daili
kaletra
lopinavirritonavir
abbott
laboratori
north
chicago
il
mg
daili
commenc
patient
respond
antibiot
within
hour
kaletra
two
proteas
inhibitor
lopinavir
ritonavir
experiment
drug
coronaviru
depend
proteas
cleavag
polypeptid
format
viral
structur
methylprednisolon
given
three
puls
dose
mg
mg
daili
offer
patient
persist
fever
radiolog
progress
lung
infiltr
sign
respiratori
distress
despit
antivir
therapi
addit
aforement
test
viral
hepat
routin
microbiolog
investig
includ
blood
urin
sputum
cultur
bacteri
pathogen
acut
convalesc
sera
test
parallel
coronaviru
immunoglobulin
g
vero
cell
fix
aceton
indirect
immunofluoresc
polymeras
chain
reaction
coronaviru
done
nasal
throat
swab
stool
specimen
liver
tissu
patient
core
liver
tissu
sent
fresh
histopatholog
laboratori
process
two
tissu
fragment
fix
glutaraldehyd
transmiss
electron
microscopi
examin
tissu
immedi
kept
frozen
c
molecular
studi
remain
core
tissu
fix
neutral
buffer
formalin
block
liver
tissu
section
light
microscopi
panel
stain
includ
hematoxylin
eosin
diastas
period
perl
gordon
sweet
reticulin
orcein
perform
number
mitos
count
hepatocyt
specimen
mitot
index
express
percentag
immunohistochem
studi
antigen
dako
rabbit
antihuman
antigen
code
perform
use
biotek
autom
immunohistochem
stainer
dako
ca
usa
human
nuclear
antigen
express
phase
cell
cycl
absent
quiescent
prolifer
hepatocyt
identifi
immunohistochem
stain
hepatocyt
distinct
nuclear
stain
consid
posit
one
thousand
hepatocyt
count
specimen
index
express
percentag
hepatocyt
nuclei
show
posit
stain
pattern
immunostain
cytomegaloviru
cmv
use
monoclon
mous
antibodi
code
also
perform
exclud
cmv
infect
total
rna
sampl
collect
use
qiaamp
viral
rna
mini
kit
qiagen
hilden
germani
accord
manufactur
instruct
rna
convert
cdna
use
superscript
ii
rnase
revers
transcriptas
invitrogen
inc
ca
usa
accord
manufactur
instruct
except
random
hexam
primer
use
place
oligo
dt
water
use
place
rnaseout
recombin
ribonucleas
inhibitor
invitrogen
inc
ca
usa
new
assay
compris
first
round
convent
pcr
follow
taqman
fluoresc
pcr
eurogenet
group
belgium
convent
pcr
follow
total
volum
follow
compon
mix
water
mm
dntp
platinum
taq
dna
polymeras
invitrogen
mm
pcr
buffer
primer
cdna
templat
ng
pcr
amplif
perform
mastercycl
eppendorf
hamburg
germani
follow
temperatur
profil
dna
polymeras
activ
c
minut
cycl
denatur
c
second
anneal
c
second
c
reduct
cycl
extens
c
second
cycl
denatur
c
second
anneal
c
second
extens
c
second
varieti
primer
convent
pcr
compar
sequenc
list
tabl
taqman
fluoresc
pcr
consist
follow
total
volum
follow
compon
mix
water
pcr
mastermix
dntp
dutp
hotstart
taq
dna
polymeras
passiv
refer
primer
c
primer
probe
e
amplifi
dna
templat
ng
cycl
amplif
perform
abi
prism
sequenc
detector
appli
biosystem
ca
usa
follow
temperatur
profil
initi
incub
c
minut
dna
polymeras
activ
c
minut
denatur
c
second
annealingextens
minut
woman
enjoy
good
health
ill
present
fever
begun
day
prior
admiss
initi
investig
show
left
upper
zone
consolid
chest
radiograph
lymphopenia
peripher
blood
examin
patient
fail
respond
levofloxacin
subsequ
radiograph
show
progress
involv
lower
zone
oral
ribavirin
kaletra
initi
day
onset
symptom
view
persist
fever
increas
oxygen
demand
puls
methylprednisolon
g
daili
prescrib
day
day
day
patient
alanin
aminotransferas
alt
level
becam
elev
iul
albumin
level
drop
gl
bilirubin
coagul
profil
normal
rash
abdomin
pain
jaundic
renal
function
test
amylas
creatin
phosphokinas
level
normal
lactic
acidosi
absent
despit
withdraw
antivir
day
alt
peak
day
iul
fig
liver
biopsi
day
show
mild
lobular
activ
occasion
acidophil
bodi
promin
kupffer
cell
portal
tract
mildli
inflam
lymphocyt
infiltr
fig
hepatocyt
show
focal
balloon
degener
fig
mitot
activ
brisk
mitot
index
fig
piecem
necrosi
eosinophil
infiltr
granuloma
cholestasi
fibrosi
steatosi
fibrin
deposit
immunostain
cmv
neg
immunohistochem
studi
use
stain
show
numer
hepatocyt
replic
phase
prolif
index
fig
abnorm
mitosi
note
electron
microscopi
show
lamin
myelin
bodi
cytoplasm
hepatocyt
kupffer
cell
microvesicular
macrovesiclar
fat
minim
neither
viral
particl
giant
mitochondria
seen
posit
liver
tissu
fig
serum
fig
patient
liver
function
improv
gradual
alt
decreas
less
iul
day
upon
discharg
experienc
full
recoveri
liver
function
test
normal
month
discharg
convalesc
serum
show
elev
antibodi
coronaviru
titer
woman
present
intermitt
fever
contact
sar
patient
hospit
serial
chest
radiograph
normal
routin
microbiolog
virolog
investig
neg
patient
develop
lymphopenia
day
day
ct
thorax
show
right
lower
lobe
consolid
posterior
retrocardiac
segment
coronaviru
posit
stool
specimen
day
ribavirin
kaletra
start
day
day
patient
still
persist
fever
ct
show
increas
involv
lung
field
alt
elev
iul
albumin
drop
gl
liver
function
subsequ
improv
fig
ribavirin
kaletra
stop
day
convalesc
serum
show
elev
antibodi
coronaviru
titer
asymptomat
liver
function
test
normal
month
discharg
liver
biopsi
day
show
similar
histolog
first
patient
mild
portal
lobular
activ
fig
occasion
acidophil
bodi
promin
mitot
figur
seen
hepatocyt
mitot
index
portal
tract
mildli
inflam
piecem
necrosi
steatosi
eosinophil
infiltr
cholestasi
seen
coronaviru
posit
liver
tissu
fig
serum
fig
prolif
index
electron
microscopi
show
small
number
elong
mitochondria
fig
myelin
bodi
hepatocyt
giant
mitochondria
steatosi
viral
particl
observ
woman
present
fever
cough
day
initi
chest
radiograph
show
bilater
lower
zone
consolid
coronaviru
nasopharyng
aspir
posit
ribavirin
kaletra
start
day
onset
symptom
fever
persist
despit
antibiot
day
patient
alt
rose
iul
bilirubin
level
increas
mmoll
mmoll
puls
methylprednisolon
given
day
persist
fever
increas
dyspnea
day
patient
improv
clinic
resolut
radiograph
abnorm
alt
increas
iul
antivir
withdrawn
liver
function
test
return
normal
day
fig
acut
convalesc
sera
neg
coronaviru
immunoglobulin
g
liver
biopsi
day
show
mild
moder
portal
lobular
inflamm
predomin
lymphocyt
infiltr
scatter
neutrophil
fig
hepatocyt
show
focal
mild
balloon
mitot
index
less
acidophil
bodi
promin
kupffer
cell
seen
piecem
necrosi
steatosi
eosinophil
infiltr
fibrin
deposit
fibrosi
seen
prolif
index
coronaviru
posit
liver
tissu
fig
serum
fig
mitot
figur
hepatocyt
identifi
section
electron
microscopi
block
fig
lipid
droplet
seen
hepatocyt
vesicular
steatosi
observ
mitochondria
elong
giant
mitochondria
identifi
kupffer
cell
contain
lysosom
march
novel
coronaviru
discov
caus
agent
sar
complet
genom
sequenc
phylogenet
analys
sequenc
comparison
show
close
relat
known
coronavirus
includ
two
human
coronavirus
diseas
spectrum
relat
novel
coronaviru
pathogenesi
yet
explor
member
genu
coronaviru
eg
mous
hepat
viru
group
coronaviru
caus
liver
damag
rang
minim
chang
fulmin
spike
protein
found
virion
envelop
plasma
membran
infect
cell
respons
attach
viral
receptor
fusion
viral
entri
fusion
latter
stage
studi
mous
hepat
viru
show
spike
gene
determin
viral
load
liver
amount
antigen
stain
necrosi
liver
correl
viral
load
mutat
spike
gene
might
abbrevi
sever
pairwis
amino
acid
ident
known
coronavirus
less
henc
hepatotrop
novel
coronaviru
unpredict
liver
impair
occur
commonli
among
patient
patient
fulfil
case
definit
clinic
sar
diagnosi
support
laboratori
test
includ
fourfold
greater
rise
antibodi
titer
acut
convalesc
phase
sera
test
parallel
patient
pcr
posit
stool
specimen
patient
nasopharyng
aspir
patient
respect
three
sar
patient
moder
mark
elev
alt
promin
mitos
acidophil
bodi
kupffer
cell
mild
moder
lobular
inflamm
common
histolog
featur
patient
show
posit
liver
tissu
sera
suggest
viru
local
liver
inde
detect
less
sera
sar
patient
beyond
day
fever
ribavirin
kaletra
given
three
patient
prior
liver
biopsi
viral
replic
might
possibl
suppress
henc
viru
could
identifi
electron
microscopi
altern
viral
load
liver
may
low
would
difficult
observ
ultrastructur
report
liver
histolog
sar
present
studi
autopsi
show
microvesicular
fatti
chang
focal
hemorrhag
hepatocyt
necrosi
scatter
acidophil
bodi
liver
viral
inclus
patient
develop
respiratori
failur
failur
death
chang
liver
histolog
might
sole
due
infect
remark
find
liver
histolog
conspicu
mitos
readili
seen
light
electron
microscopi
immunohistochem
studi
use
stain
show
hepatocyt
highli
replic
prolif
index
also
report
chronic
activ
hepat
index
acut
viral
hepat
remain
unknown
howev
hepatocyt
mitot
phase
uncommonli
seen
even
acut
chronic
hepat
liver
cirrhosi
even
regener
take
place
find
conspici
mitos
patient
appear
proport
extent
liver
cell
damag
assess
biochem
histolog
possibl
cell
cycl
disrupt
caus
coronaviru
consid
studi
transmiss
gastroenter
viru
group
coronaviru
mous
hepat
viru
show
nucleolar
local
nucleoprotein
n
protein
common
featur
coronaviru
famili
vero
cell
transfect
nucleoprotein
appear
undergo
cell
observ
also
report
avian
infecti
bronchiti
viru
group
coronaviru
delay
mitosi
inhibit
cytokinesi
could
lead
accumul
cell
phase
cell
cycl
henc
appear
signific
number
cell
undergo
cell
divis
unlik
patient
patient
neg
serolog
despit
repeatedli
posit
result
nasal
throat
swab
liver
tissu
lack
immunoglobulin
g
seroconvers
describ
patient
liver
biopsi
patient
also
show
higher
lobular
activ
less
promin
mitot
figur
might
repres
anoth
spectrum
diseas
result
differ
host
respons
viru
common
patholog
featur
among
three
liver
specimen
presenc
acidophil
bodi
balloon
hepatocyt
mild
moder
lobular
activ
similar
hepat
patholog
mous
hepat
viru
find
suggest
liver
damag
due
mainli
mediat
apoptosi
studi
show
coronavirus
exert
extens
cytopath
effect
induct
apoptosi
host
cell
caspas
mous
hepat
viru
also
activ
immun
coagul
system
gene
encod
specif
prothrombinas
induc
macrophag
procoagul
turn
lead
fibrin
deposit
endothelium
intrahepat
vein
hepat
sinusoid
result
confluent
hepatocellular
necrosi
howev
specimen
show
sinusoid
dilat
fibrin
deposit
hepat
vein
hand
fibrin
thrombi
intim
swell
pulmonari
vessel
report
among
patient
altern
explan
liver
impair
sar
patient
hepatotox
due
antivir
treatment
kaletra
use
treatment
sar
patient
hong
kong
preliminari
result
show
mortal
intub
rate
lower
group
compar
patient
treat
elev
alt
greater
fivefold
upper
limit
normal
report
patient
take
ribavirin
also
increas
mitochondri
toxic
patient
treat
proteas
howev
favor
possibl
hepatotox
usual
develop
use
antivir
agent
furthermor
patient
pancreat
myopathi
lactic
acidosi
clinic
featur
suggest
mitochondri
toxic
occasion
hepatotox
may
occur
first
week
initi
antivir
therapi
typic
relat
hypersensit
gener
occur
conjunct
allerg
reaction
fever
howev
patient
clinic
featur
liver
biopsi
show
eosinophilia
giant
mitochondria
microvesicular
steatosi
suggest
drug
furthermor
consist
tempor
relationship
antivir
treatment
liver
function
impair
primari
human
hepatocyt
ribavirin
also
inhibit
cell
prolifer
induc
mitogen
factor
way
delay
progress
phase
cell
howev
liver
histolog
patient
chronic
hepat
c
show
featur
cell
cycl
arrest
ribavirin
studi
warrant
determin
whether
infect
like
chronic
hepat
b
c
viru
may
increas
hepatotox
antivir
conclus
infect
liver
lead
mild
moder
lobular
inflamm
apoptosi
presenc
promin
mitos
among
hepatocyt
possibl
due
hyperprolif
state
cell
cycl
arrest
cardin
featur
liver
patholog
sar
better
knowledg
pathogenesi
infect
includ
possibl
viral
replic
hepatocyt
specif
therapi
may
target
reduc
viral
replic
modifi
clinic
cours
diseas
